These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 11881427)

  • 21. Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group.
    Posthuma N; ter Wee PM; Donker AJ; Oe PL; Peers EM; Verbrugh HA
    Perit Dial Int; 2000; 20 Suppl 2():S106-13. PubMed ID: 10911654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload.
    Johnson DW; Arndt M; O'Shea A; Watt R; Hamilton J; Vincent K
    BMC Nephrol; 2001 Dec; 2():2. PubMed ID: 11737871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polyglucose dialysis solution induces changes in blood chemistry.
    Grzegorzewska AE; Antczak-Jedrzejczak D; Leander M; Mariak I
    Adv Perit Dial; 2001; 17():101-8. PubMed ID: 11510254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum disaccharides and osmolality in CCPD patients using icodextrin or glucose as daytime dwell.
    Posthuma N; ter Wee PM; Donker AJ; Oe PL; van Dorp W; Peers EM; Verbrugh HA
    Perit Dial Int; 1997; 17(6):602-7. PubMed ID: 9655161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peritoneal ultrafiltration and serum icodextrin concentration during dialysis with 7.5% icodextrin solution in Japanese patients.
    Ota K; Akiba T; Nakao T; Nakayama M; Maeba T; Park MS; Tranaeus A; Yorioka N;
    Perit Dial Int; 2003; 23(4):356-61. PubMed ID: 12968843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of a favourable response to icodextrin in peritoneal dialysis patients with ultrafiltration failure.
    Wiggins KJ; Rumpsfeld M; Blizzard S; Johnson DW
    Nephrology (Carlton); 2005 Feb; 10(1):33-6. PubMed ID: 15705179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of peritoneal dialysis solution type on serum lipid levels in end-stage renal disease.
    Kanbay M; Bavbek N; Delibasi T; Koca C; Kaya A; Altay M; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2007; 29(3):309-13. PubMed ID: 17497445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of clinical trial experience with icodextrin.
    Wolfson M; Ogrinc F; Mujais S
    Kidney Int Suppl; 2002 Oct; (81):S46-52. PubMed ID: 12230481
    [No Abstract]   [Full Text] [Related]  

  • 29. Hyperinsulinism reduction associated with icodextrin treatment in continuous ambulatory peritoneal dialysis patients.
    Amici G; Orrasch M; Da Rin G; Bocci C
    Adv Perit Dial; 2001; 17():80-3. PubMed ID: 11510303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe peritoneal mononucleosis associated with icodextrin use in continuous ambulatory peritoneal dialysis.
    Martín J; Sansone G; Cirugeda A; Sánchez-Tomero JA; Muñoz C; Selgas R
    Adv Perit Dial; 2003; 19():191-4. PubMed ID: 14763060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allergic reactions to the polymeric glucose-based peritoneal dialysis fluid icodextrin in patients with renal failure.
    Goldsmith D; Jayawardene S; Sabharwal N; Cooney K
    Lancet; 2000 Mar; 355(9207):897. PubMed ID: 10752708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The utility of two daytime icodextrin exchanges to reduce dextrose exposure in automated peritoneal dialysis patients: a pilot study of nine patients.
    Gobin J; Fernando S; Santacroce S; Finkelstein FO
    Blood Purif; 2008; 26(3):279-83. PubMed ID: 18421212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Icodextrin with nitroprusside increases ultrafiltration and peritoneal transport during long CAPD dwells.
    Douma CE; Hiralall JK; de Waart DR; Struijk DG; Krediet RT
    Kidney Int; 1998 Apr; 53(4):1014-21. PubMed ID: 9551412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of icodextrin in peritoneal dialysis patients.
    Moberly JB; Mujais S; Gehr T; Hamburger R; Sprague S; Kucharski A; Reynolds R; Ogrinc F; Martis L; Wolfson M
    Kidney Int Suppl; 2002 Oct; (81):S23-33. PubMed ID: 12230479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Peritoneal equilibrium test using icodextrin and glucose at different concentrations].
    Guerrero A; Montes R; Martín-Herrera C; Ruiz A; Gallego T; Delgado-Pecellín C; Benítez M; Torán CD
    Nefrologia; 2002; 22(4):340-7. PubMed ID: 12369125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe cutaneous hypersensitivity requiring permanent icodextrin withdrawal in a CAPD patient.
    Queffeulou G; Bernard M; Vrtovsnik F; Skhiri H; Lebrun-Vigne B; Hufnagel G; Michel C; Mignon F
    Clin Nephrol; 1999 Mar; 51(3):184-6. PubMed ID: 10099892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Icodextrin in peritoneal dialysis therapy].
    Grzegorzewska AE; Antczak-Jedrzejczak D
    Przegl Lek; 1999; 56(12):812-6. PubMed ID: 10789195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized controlled study of icodextrin on the treatment of peritoneal dialysis patients during acute peritonitis.
    Chow KM; Szeto CC; Kwan BC; Pang WF; Ma T; Leung CB; Law MC; Li PK
    Nephrol Dial Transplant; 2014 Jul; 29(7):1438-43. PubMed ID: 24578470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Icodextrin: an alternative peritoneal dialysis fluid.
    Chhabra D; Nash K
    Expert Opin Drug Metab Toxicol; 2008 Nov; 4(11):1455-64. PubMed ID: 18950286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful use of icodextrin in elderly patients on continuous ambulatory peritoneal dialysis.
    Nakamoto H; Babazono T; Kasai K; Kuriyama S; Sugimoto T; Nakayama M; Hamada C; Furuya R; Hasegawa H; Kasahara M; Moriishi M; Tomo T; Miyazaki M; Yorioka N; Sato M; Yamabe K; Kawaguchi Y
    Adv Perit Dial; 2005; 21():168-74. PubMed ID: 16686312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.